| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.CYTOGFR.2007.10.007 |
| P698 | PubMed publication ID | 18068417 |
| P2093 | author name string | Agnès Le Bon | |
| David F Tough | |||
| P433 | issue | 1 | |
| P304 | page(s) | 33-40 | |
| P577 | publication date | 2008-02-01 | |
| P1433 | published in | Cytokine and Growth Factor Reviews | Q15763303 |
| P1476 | title | Type I interferon as a stimulus for cross-priming | |
| P478 | volume | 19 |
| Q40440208 | A Lymphotoxin/Type I IFN Axis Programs CD8+ T Cells To Infiltrate a Self-Tissue and Propagate Immunopathology |
| Q37372465 | Absence of IFN-beta impairs antigen presentation capacity of splenic dendritic cells via down-regulation of heat shock protein 70. |
| Q30367140 | Activation of the RIG-I pathway during influenza vaccination enhances the germinal center reaction, promotes T follicular helper cell induction, and provides a dose-sparing effect and protective immunity. |
| Q36087235 | Altered expression of cytokine signaling pathway genes in peripheral blood cells of alcohol dependent subjects: preliminary findings |
| Q57955465 | CAF05: cationic liposomes that incorporate synthetic cord factor and poly(I:C) induce CTL immunity and reduce tumor burden in mice |
| Q45373249 | Concomitant type I IFN receptor-triggering of T cells and of DC is required to promote maximal modified vaccinia virus Ankara-induced T-cell expansion |
| Q35728237 | Control of type I interferon-induced cell death by Orai1-mediated calcium entry in T cells |
| Q36139716 | Curative one-shot systemic virotherapy in murine myeloma |
| Q24603625 | Cytopathic bovine viral diarrhea viruses (BVDV): emerging pestiviruses doomed to extinction |
| Q59415968 | Dendritic cells adhere to and transmigrate across lymphatic endothelium in response to IFN-α |
| Q38110935 | Dendritic cells in myelodysplastic syndromes: from pathogenesis to immunotherapy. |
| Q30318566 | Dendritic cells transfected with Her2 antigen-encoding RNA replicons cross-prime CD8 T cells and protect mice against tumor challenge |
| Q37744071 | Designing CD8+ T cell vaccines: it's not rocket science (yet). |
| Q34615006 | Differential activity of type I interferon subtypes for dendritic cell differentiation |
| Q35094040 | H5N1 influenza vaccine formulated with AS03 A induces strong cross-reactive and polyfunctional CD4 T-cell responses. |
| Q33902330 | Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens. |
| Q56975166 | Human blood mDC subsets exhibit distinct TLR repertoire and responsiveness |
| Q37059705 | Human metapneumovirus small hydrophobic (SH) protein downregulates type I IFN pathway signaling by affecting STAT1 expression and phosphorylation |
| Q64122061 | IFN Signaling in Inflammation and Viral Infections: New Insights from Fish Models |
| Q54615870 | IFN-α-producing PDCA-1+ Siglec-H- B cells mediate innate immune defense by activating NK cells. |
| Q26778206 | IFN-γ Priming Effects on the Maintenance of Effector Memory CD4(+) T Cells and on Phagocyte Function: Evidences from Infectious Diseases |
| Q38060973 | Identification and utility of innate immune system evasion mechanisms of ASFV. |
| Q92800268 | Immune Conversion of Tumor Microenvironment by Oncolytic Viruses: The Protoparvovirus H-1PV Case Study |
| Q34199805 | Immune responses in pigs vaccinated with adjuvanted and non-adjuvanted A(H1N1)pdm/09 influenza vaccines used in human immunization programmes |
| Q34022013 | Immunomodulatory Effects of dsRNA and Its Potential as Vaccine Adjuvant |
| Q34077504 | Immunosuppressive small molecule discovered by structure-based virtual screening for inhibitors of protein-protein interactions |
| Q38533606 | Immunotherapy in acute myeloid leukemia |
| Q36700481 | Immunovirotherapy with vesicular stomatitis virus and PD-L1 blockade enhances therapeutic outcome in murine acute myeloid leukemia |
| Q40324020 | Impairment of CD4+ T cell polarization by dengue virus-infected dendritic cells |
| Q35845445 | Increased IFN-α-producing plasmacytoid dendritic cells (pDCs) in human Th1-mediated type 1 diabetes: pDCs augment Th1 responses through IFN-α production |
| Q34075613 | Increased antigen presentation but impaired T cells priming after upregulation of interferon-beta induced by lipopolysaccharides is mediated by upregulation of B7H1 and GITRL |
| Q27315168 | Innate killing of Leishmania donovani by macrophages of the splenic marginal zone requires IRF-7 |
| Q37832939 | Interferon-α in acute myeloid leukemia: an old drug revisited |
| Q39560812 | MHV-68 producing mIFNα1 is severely attenuated in vivo and effectively protects mice against challenge with wt MHV-68. |
| Q37726746 | Measure and countermeasure: type I IFN (IFN-alpha/beta) antiviral response against West Nile virus |
| Q90218846 | Mechanisms of Leukemia Immune Evasion and Their Role in Relapse After Haploidentical Hematopoietic Cell Transplantation |
| Q35608178 | Mechanisms of antigen presentation to T cells in murine graft-versus-host disease: cross-presentation and the appearance of cross-presentation |
| Q36200046 | Mesenchymal stromal cells inhibit murine syngeneic anti-tumor immune responses by attenuating inflammation and reorganizing the tumor microenvironment |
| Q92914662 | Microfluidic-prepared DOTAP nanoparticles induce strong T-cell responses in mice |
| Q44354106 | Monoclonal antibodies to equine interferon-alpha (IFN-alpha): new tools to neutralize IFN-activity and to detect secreted IFN-alpha |
| Q37763996 | Non-cytotoxic antiviral activities of granzymes in the context of the immune antiviral state. |
| Q27022525 | Nucleic acids and endosomal pattern recognition: how to tell friend from foe? |
| Q27488206 | Oncostatin M Enhances the Antiviral Effects of Type I Interferon and Activates Immunostimulatory Functions in Liver Epithelial Cells |
| Q35312451 | Phenotypic, ultra-structural, and functional characterization of bovine peripheral blood dendritic cell subsets |
| Q30422031 | Plasmacytoid dendritic cell ablation impacts early interferon responses and antiviral NK and CD8(+) T cell accrual |
| Q35259804 | Plasmacytoid dendritic cells and the control of herpesvirus infections. |
| Q33940675 | Poly(I:C) enhances the susceptibility of leukemic cells to NK cell cytotoxicity and phagocytosis by DC |
| Q39804029 | PolyI:C plus IL-2 or IL-12 induce IFN-gamma production by human NK cells via autocrine IFN-beta. |
| Q36754331 | Polyinosinic-polycytidylic acid is the most effective TLR adjuvant for SIV Gag protein-induced T cell responses in nonhuman primates |
| Q33924457 | Porcine type I interferons: polymorphic sequences and activity against PRRSV. |
| Q35607012 | Porous silicon microparticle potentiates anti-tumor immunity by enhancing cross-presentation and inducing type I interferon response |
| Q55652233 | Preclinical Development of Oncolytic Immunovirotherapy for Treatment of HPVPOS Cancers. |
| Q39665878 | Prolonged antigen storage endows merocytic dendritic cells with enhanced capacity to prime anti-tumor responses in tumor-bearing mice |
| Q37259634 | Promises and challenges for the development of Listeria monocytogenes-based immunotherapies |
| Q37829145 | Respiratory and gastrointestinal epithelial modulation of the immune response during viral infection. |
| Q33619103 | Role of PKR and Type I IFNs in viral control during primary and secondary infection. |
| Q41013010 | Role of type I interferon signaling in human metapneumovirus pathogenesis and control of viral replication |
| Q39607848 | Selective expansion of merocytic dendritic cells and CD8DCs confers anti-tumour effect of Fms-like tyrosine kinase 3-ligand treatment in vivo. |
| Q40411379 | Successive Intramuscular Boosting with IFN-Alpha Protects Mycobacterium bovis BCG-Vaccinated Mice against M. lepraemurium Infection |
| Q34576048 | TLR-9 contributes to the antiviral innate immune sensing of rodent parvoviruses MVMp and H-1PV by normal human immune cells |
| Q39076005 | The Essential Role of Type I Interferons in Differentiation and Activation of Tumor-Associated Neutrophils |
| Q38102693 | The Regulation of Immune Responses by DC Derived Type I IFN. |
| Q37294444 | The administration route is decisive for the ability of the vaccine adjuvant CAF09 to induce antigen-specific CD8(+) T-cell responses: The immunological consequences of the biodistribution profile |
| Q33584744 | The carboxy terminal region of the human cytomegalovirus immediate early 1 (IE1) protein disrupts type II inteferon signaling |
| Q46853154 | The intricate interplay between RNA viruses and NF-κB. |
| Q40082688 | The neuropathogenic T953 strain of equine herpesvirus-1 inhibits type-I IFN mediated antiviral activity in equine endothelial cells |
| Q30528191 | The simultaneous ex vivo detection of low-frequency antigen-specific CD4+ and CD8+ T-cell responses using overlapping peptide pools. |
| Q36611354 | Timing and magnitude of type I interferon responses by distinct sensors impact CD8 T cell exhaustion and chronic viral infection |
| Q47095345 | Toll-Like Receptor 4, but Not Neutrophil Extracellular Traps, Promote IFN Type I Expression to Enhance Th2 Responses to Nippostrongylus brasiliensis |
| Q37411480 | Transcriptional re-programming of primary macrophages reveals distinct apoptotic and anti-tumoral functions of IRF-3 and IRF-7. |
| Q45324494 | Transcriptome analysis of plasmid-induced genes sheds light on the role of type I IFN as adjuvant in DNA vaccine against infectious salmon anemia virus. |
| Q38654647 | Type I IFN and not TNF, is Essential for Cyclic Di-nucleotide-elicited CTL by a Cytosolic Cross-presentation Pathway |
| Q38176613 | Type I Interferons as Stimulators of DC-Mediated Cross-Priming: Impact on Anti-Tumor Response |
| Q91841187 | Type I interferon in HIV treatment: from antiviral drug to therapeutic target |
| Q37652531 | Type I interferons as mediators of immune adjuvants for T- and B cell-dependent acquired immunity |
| Q43163173 | Vesicular stomatitis virus M protein mutant stimulates maturation of Toll-like receptor 7 (TLR7)-positive dendritic cells through TLR-dependent and -independent mechanisms |
Search more.